TM-P4-Thal

N/A

Report date: 2022/12/29 15:53:20
NME

Base Information

Drug NameTM-P4-Thal
Drug Alias NameTM-P4-ThalTM-P-4-Thal
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 degraders
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCornell University
China Registration ClassN/A

Develop Information

Active CompaniesCornell University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A